20 Volunteers Suffer Serious Reactions to Johnson & Johnson’s COVID-19 Vaccine
![20 Volunteers Suffer Serious Reactions to Johnson & Johnson’s COVID-19 Vaccine 20 Volunteers Suffer Serious Reactions to Johnson & Johnson’s COVID-19 Vaccine](https://thevaccinereaction.org/wp-content/uploads/2020/10/pain-1024x682.jpg)
On Sept. 23, 2020, U.S. pharmaceutical and medical devices company Johnson & Johnson, Inc. announced the start of the Phase 3 human clinical trial for its experimental Ad26.COV2.S vaccine for COVID-19. The New Jersey-based company, which is partnering with its subsidiary Janssen Pharmaceutica NV of Belgium on development of the vaccine, is planning to enroll […]
AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event
![AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event](https://thevaccinereaction.org/wp-content/uploads/2020/09/coronavirus-vaccine-testing-1024x682.jpg)
News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]
COVID-19 Vaccine Mandate Unlikely in Canada Say Health Officials
![COVID-19 Vaccine Mandate Unlikely in Canada Say Health Officials COVID-19 Vaccine Mandate Unlikely in Canada Say Health Officials](https://thevaccinereaction.org/wp-content/uploads/2020/09/Canadian-flags-1024x686.jpg)
The government of Canada has signed deals to purchase COVID-19 vaccines from four pharmaceutical companies when their vaccines are approved to be given to the public. According to Canada’s Minister of Public Services and Procurement Anita Anand, the Canadian government has contracts with Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Moderna, Novavax and Pfizer […]
Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans
![Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans](https://thevaccinereaction.org/wp-content/uploads/2020/06/cows-1024x509.jpg)
Story Highlights Human trials for a new COVID-19 immunotherapy candidate (SAB-185) that is derived from genetically engineered cow plasma will begin in July 2020. The cows have been genetically engineered to produce human antibodies to fight off COVID-19. Plasma from the cows is expected to assist COVID-19 patients overcome the infection. SAb Biotherapeutics (SAB), a […]
COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually
![COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually](https://thevaccinereaction.org/wp-content/uploads/2020/06/doctor-with-syringes-1024x682.jpg)
In an interview with the JAMAÂ on June 2, 2020, Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said that while he was “cautiously optimistic” about the effectiveness of the vaccines being developed for COVID-19, he was concerned that any protection the vaccines may provide might only be temporary. […]
GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant
![GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant](https://thevaccinereaction.org/wp-content/uploads/2020/05/army-worms.jpg)
Story Highlights GlaxoSmithKline and Sanofi Pasteur are partnering to develop an experimental COVID-19 vaccine. The two global vaccine manufacturers are using existing recombinant DNA vaccine technology and a squalene adjuvant for their COVID-19 vaccine. Clinical trials are scheduled to begin in the second half of 2020 and, if successful, the vaccine will be available in […]